Company / Book Value per Share
Niagen Bioscience, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.99
FY2025
5-year range
$0.265 / $0.99
FY2021-FY2025
Trend
+160.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $0.99.
Based on SEC 10-K filings.
$0.99 in FY2025 with a 5-year CAGR of +23.6%.
Improved from $0.385 to $0.99 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +28.6%
- 5-Year CAGR
- +23.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +23.6%, indicating consistent growth.
- In FY2025, book value per share increased 160.8% year-over-year.
- Peak book value per share was recorded in FY2019.
- Lowest book value per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.99 | +160.8% |
| FY2024 | $0.38 | -1.3% |
| FY2023 | $0.385 | -17.4% |
| FY2022 | $0.466 | +75.5% |
| FY2021 | $0.265 | -22.7% |
| FY2020 | $0.343 | -99.9% |
| FY2019 | $371.127 | +37607.6% |
| FY2018 | $0.984 | -31.4% |
| FY2017 | $1.434 | +417.6% |
| FY2016 | $0.277 | +452.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026